BCL7A anticorps (AA 40-120)

N° du produit ABIN7224034

Cet anticorps Lapin Polyclonal détecte spécifiquement BCL7A dans WB et ELISA. Il présente une réactivité envers Humain et Souris.

Aperçu rapide pour BCL7A anticorps (AA 40-120) (ABIN7224034)

Antigène: BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp BCL7A est non-conjugé

Application: Western Blotting (WB), ELISA

Détail du produit anti-BCL7A anticorps

Épitope: AA 40-120

Fonction: Bcl-7a Polyclonal Antibody

Specificité: Bcl-7a Polyclonal Antibody detects endogenous levels of Bcl-7a protein.

Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen

Immunogène: Synthesized peptide derived from the Internal region of human Bcl-7a at AA range: 40-120

Isotype: IgG

Information d'application

Indications d'application: Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB (1:500-1:2000), ELISA (1:5000). Not yet tested in other applications.

Commentaires:

Primary Antibody

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: PBS containing 50 % Glycerol, 0.5 % BSA and 0.02 % Sodium Azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Détails sur BCL7A

Antigène: BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))

Autre désignation: Bcl-7a

Sujet: Rabbit Anti-Bcl-7a Polyclonal Antibody,BCL7A, B-cell CLL/lymphoma 7 protein family member A,BCL7A (BCL tumor suppressor 7A) is directly involved, with Myc and IgH, in a three-way gene translocation in a Burkitt lymphoma cell line. As a result of the gene translocation, the N-terminal region of the gene product is disrupted, which is thought to be related to the pathogenesis of a subset of high-grade B cell non-Hodgkin lymphoma. The N-terminal segment involved in the translocation includes the region that shares a strong sequence similarity with those of BCL7B and BCL7C. Two transcript variants encoding different isoforms have been found for BCL7A.,B-cell CLL

ID gène: 605

UniProt: Q4VC05